Solid Biosciences Inc.
SLDB
$5.11
-$0.10-1.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.20M | 9.28M | 9.14M | 9.13M | 7.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.06M | 41.69M | 40.05M | 39.90M | 35.18M |
| Operating Income | -48.06M | -41.69M | -40.05M | -39.90M | -35.18M |
| Income Before Tax | -45.78M | -39.48M | -39.28M | -42.60M | -32.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.78M | -39.48M | -39.28M | -42.60M | -32.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.78M | -39.48M | -39.28M | -42.60M | -32.73M |
| EBIT | -48.06M | -41.69M | -40.05M | -39.90M | -35.18M |
| EBITDA | -47.68M | -41.31M | -39.65M | -39.41M | -34.78M |
| EPS Basic | -0.48 | -0.42 | -0.59 | -1.00 | -0.79 |
| Normalized Basic EPS | -0.30 | -0.26 | -0.37 | -0.62 | -0.49 |
| EPS Diluted | -0.48 | -0.42 | -0.59 | -1.00 | -0.79 |
| Normalized Diluted EPS | -0.30 | -0.26 | -0.37 | -0.62 | -0.49 |
| Average Basic Shares Outstanding | 94.42M | 94.14M | 66.34M | 42.71M | 41.44M |
| Average Diluted Shares Outstanding | 94.42M | 94.14M | 66.34M | 42.71M | 41.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |